ONMD.NASDAQOnemednet CORP

8-K: OneMedNet Amends Securities Purchase Agreement, Clarifies Lock-Up Terms and Initial Funding Release

Sentiment:

Material Definitive Agreement Amendment


OneMedNet Corporation amended its Securities Purchase Agreement to clarify the timing of the initial funding release and lock-up agreements, contingent on refiling its registration statement.

Capital raiseThe amendment relates to the initial tranche of a securities purchase agreement.The initial tranche includes notes and warrants.The amendment clarifies the timing of the release of $350,000 from the initial tranche.

Summary

  • OneMedNet Corporation has amended its Securities Purchase Agreement with investors, effective June 4, 2024.
  • The amendment clarifies that the initial tranche closing will occur after the company refiles its S-1 registration statement with the SEC.
  • Upon refiling, $350,000 of the initial tranche proceeds, minus closing costs, will be immediately released to the company.
  • The amendment also defers the lock-up agreement effective date to when the S-1 becomes effective.
  • The threshold for major shareholders subject to lock-up agreements has been increased from 4% to 10%.

Sentiment

Score: 7

Explanation: The amendment provides clarity and some immediate funding, which is positive. However, the dependence on the S-1 refiling introduces some uncertainty.

Positives

  • The amendment provides clarity on the timing of the initial funding release.
  • The immediate release of $350,000 upon refiling provides the company with immediate capital.
  • The deferred lock-up agreement provides more flexibility for shareholders.
  • The increased major shareholder threshold for lock-up agreements reduces the number of shareholders affected.

Risks

  • The release of funds is contingent on the successful refiling of the S-1 registration statement.
  • Delays in refiling the S-1 could delay the release of funds.
  • The lock-up agreement, while deferred, still restricts the sale of shares for six months after the S-1 becomes effective.

Future Outlook

The company anticipates the closing of the initial tranche to occur promptly after refiling the S-1 registration statement.

Management Comments

  • Aaron Green, CEO of OneMedNet, signed the amendment on behalf of the company.

Industry Context

This amendment is a common step in private placements, ensuring that both the company and investors have clear terms regarding funding and share restrictions. It is not unusual for companies to adjust terms based on market conditions and regulatory requirements.

Comparison to Industry Standards

  • Lock-up agreements are standard practice in private placements to prevent large share sales immediately after a financing event, which could negatively impact the share price.
  • The 10% threshold for major shareholders is a common benchmark, although some agreements may use lower thresholds.
  • The release of funds upon a specific milestone, such as refiling an S-1, is a typical condition in such agreements.

Stakeholder Impact

  • Shareholders will be impacted by the lock-up agreement, which restricts the sale of shares for six months after the S-1 is effective.
  • The company will receive $350,000 in funding upon refiling the S-1, which will support operations.

Next Steps

  • OneMedNet needs to refile its S-1 registration statement with the SEC.
  • The initial tranche closing will occur promptly after the S-1 refiling.
  • The lock-up agreements will become effective once the S-1 is effective.

Key Dates

DateDescription
2024-03-28Date of the original Securities Purchase Agreement.
2024-06-04Effective date of the Amendment to the Securities Purchase Agreement.
2024-06-06Date the 8-K report was signed.

Keywords

Securities Purchase Agreement, Amendment, Initial Tranche, Lock-Up Agreement, S-1 Registration Statement, Funding, Investors

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.